Columbus, NE, facility will be center of excellence by 2021
Medtech giant BD (Becton, Dickinson and Company) will be investing over $60 million to transform the manufacturing facility in Columbus, NE, into a plastic injection molding manufacturing center of excellence by 2021.
BD is one of the largest users of injection molded thermoplastic components, BD uses over 700 billion injection molded components every year. Per BD currently a large percentage of the thermoplastic component molding is performed by suppliers in North America, which will be brought in house over the next 4 years.
The invest has been scheduled over the next four-year period, BD stated that they are planning to continue the manufacturing of their glass syringe product which is used for the pre-fillable applications while the facility undergoes its transformation.
“Columbus is home to BD’s largest and longest-running manufacturing facility in the world, and we are excited to bring cutting-edge technology and production to the area,” said Steve Sichak, Executive Vice President and Chief Integrated Supply Chain Officer. “Columbus will be the centerpiece for our plastic molding manufacturing strategy for North America, supporting multiple business units in the U.S. and around the world.”
BD also plans to dedicate up to $ 7 million towards talent retention and retraining its workforce. Expansion and introduction of thermoplastic injection molding and other associated processes are the primary drivers for the retraining commitment. Company is partnering with local and state officials to develop the necessary training programs and curriculum to be administered in educational institutions in the Columbus area.
In fall of 2016, BD announced a $100 million investment in its Holdrege, NE, facility to expand capacity for its insulin syringe manufacturing operations, bringing BD’s total commitment to Nebraska to $160 million in the past eight months alone. In addition to Columbus and Holdrege, BD also has operations in Broken Bow, NE, and employs approximately 2,500 people across the state.
Late last month, BD also announced that it will acquire C.R. Bard Inc., a medical technology company specialized in the fields of vascular, urology, oncology and surgical products for $24 billion. The combination will create a highly differentiated medical technology company uniquely positioned to improve both the process of care and the treatment of disease for patients and healthcare providers, said the company in a news release published on April 23.
The author, KetanDeshpande, lives in Minnesota and writes about a variety of topics in his blog such as global economy, market and industry trends, successful strategies for businesses, and others. Leveraging his global strategic leadership experience from the manufacturing industry to offer insights in to how businesses can meet the sustainable growth and profitability goals.
Ketan Deshpande is also passionate about sustainability and renewable energy; he curates and shares latest updates in his blog posts. Recently the Southern Minnesota Municipal Power Agency(SMMPA) of Litchfield, Minnesota, endorsed Ketan Deshpande for an energy conservation project.
This blog also features memorable events, travel experiences and his favorite places to visit in the great state of Minnesota.
Blog by Ketan Sharad Deshpande, Anoka county, Minnesota, MN